378 related articles for article (PubMed ID: 18030050)
1. Recurrent hepatic epithelioid hemangioendothelioma: detection by FDG PET/CT.
Lin E; Agoff N
Clin Nucl Med; 2007 Dec; 32(12):949-51. PubMed ID: 18030050
[TBL] [Abstract][Full Text] [Related]
2. F-18 FDG PET/CT monitoring of radiation therapeutic effect in hepatic epithelioid hemangioendothelioma.
Suga K; Kawakami Y; Hiyama A; Hori K
Clin Nucl Med; 2009 Mar; 34(3):199-202. PubMed ID: 19352294
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET/CT in the evaluation of epithelioid hemangioendothelioma of the liver: the role of dual-time-point imaging. A case presentation and review of the literature.
Kitapci MT; Akkaş BE; Gullu I; Sokmensuer C
Ann Nucl Med; 2010 Aug; 24(7):549-53. PubMed ID: 20414751
[TBL] [Abstract][Full Text] [Related]
4. MRI and FDG PET/CT findings of hepatic epithelioid hemangioendothelioma.
Dong A; Dong H; Wang Y; Gong J; Lu J; Zuo C
Clin Nucl Med; 2013 Feb; 38(2):e66-73. PubMed ID: 22996250
[TBL] [Abstract][Full Text] [Related]
5. Complete metabolic response to therapy of hepatic epithelioid hemangioendothelioma evaluated with 18F-fluorodeoxyglucose positron emission tomography/contrast-enhanced computed tomography: A CARE case report.
Giancipoli RG; Monti S; Basturk O; Klimstra D; Keohan ML; Schillaci O; Corrias G; Sawan P; Mannelli L
Medicine (Baltimore); 2018 Oct; 97(42):e12795. PubMed ID: 30334971
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG-PET/CT as an indicator for resection of pulmonary epithelioid hemangioendothelioma.
Watanabe S; Yano F; Kita T; Soga S; Shinmoto H; Kosuda S; Ozeki Y; Aida S; Sakata I
Ann Nucl Med; 2008 Jul; 22(6):521-4. PubMed ID: 18670859
[TBL] [Abstract][Full Text] [Related]
7. Malignant epithelioid hemangioendothelioma of the lower extremity: staging with F-18 FDG PET/CT.
Makis W; Ciarallo A; Nahal A; Derbekyan V
Clin Nucl Med; 2011 Jul; 36(7):590-2. PubMed ID: 21637069
[TBL] [Abstract][Full Text] [Related]
8. [A case of epithelioid hemangioendothelioma of the liver: detection by FDG-PET].
Katsushima S; Komeda T; Endoh B; Mizumoto Y; Watanabe T; Shima N; Adachi E; Kitaoka S; Hashiba M; Tomono T; Esaka N; Ohta Y; Tanaka Y; Morimoto H; Kuroda E; Ohta R; Maekawa T; Minamiguchi S
Nihon Shokakibyo Gakkai Zasshi; 2009 Nov; 106(11):1650-9. PubMed ID: 19893296
[TBL] [Abstract][Full Text] [Related]
9. FDG PET/CT Findings of Multifocal Epithelioid Hemangioendotheliomas of the Bones.
Rao M; Chen Y; Huang Z; Zhu Y; Xiao X
Clin Nucl Med; 2015 Oct; 40(10):821-2. PubMed ID: 26018717
[TBL] [Abstract][Full Text] [Related]
10. Epithelioid hemangioendothelioma of the liver with F-18 FDG PET imaging.
Nguyen BD
Clin Nucl Med; 2004 Dec; 29(12):828-30. PubMed ID: 15545895
[No Abstract] [Full Text] [Related]
11.
Ozguven S; Kesim S; Oksuzoglu K; Dane F; Ones T; Erdil TY
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):39-40. PubMed ID: 31594699
[No Abstract] [Full Text] [Related]
12. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
[TBL] [Abstract][Full Text] [Related]
13. Diffuse hepatic epithelioid hemangioendothelioma with multiple splenic metastasis and delayed multifocal bone metastasis after liver transplantation on FDG PET/CT images: A case report.
Tan Y; Yang X; Dong C; Xiao Z; Zhang H; Wang Y
Medicine (Baltimore); 2018 Jun; 97(22):e10728. PubMed ID: 29851777
[TBL] [Abstract][Full Text] [Related]
14. 18 F-FDG PET/CT Imaging of Prostatic Epithelioid Hemangioendothelioma.
Deng Y; Deng Y; He L; Zhang W; Lei X
Clin Nucl Med; 2024 Feb; 49(2):191-192. PubMed ID: 38049968
[TBL] [Abstract][Full Text] [Related]
15. The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
Wudel LJ; Delbeke D; Morris D; Rice M; Washington MK; Shyr Y; Pinson CW; Chapman WC
Am Surg; 2003 Feb; 69(2):117-24; discussion 124-6. PubMed ID: 12641351
[TBL] [Abstract][Full Text] [Related]
16. Increased FDG uptake in pulmonary epitheloid hemangioendothelioma.
Ergün EL; Lim E
Rev Esp Med Nucl; 2006; 25(3):188-92. PubMed ID: 16762274
[TBL] [Abstract][Full Text] [Related]
17. [18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy.
Samim M; El-Haddad GE; Molenaar IQ; Prevoo W; van den Bosch MA; Alavi A; Lam MG
PET Clin; 2014 Oct; 9(4):469-95, vi. PubMed ID: 26050948
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study.
Langenhoff BS; Oyen WJ; Jager GJ; Strijk SP; Wobbes T; Corstens FH; Ruers TJ
J Clin Oncol; 2002 Nov; 20(22):4453-8. PubMed ID: 12431968
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of pre-and postoperative 18F-FDG PET/CT in patients undergoing liver transplantation for hepatocellular carcinoma.
Wang XL; Li H; Wang QS; Zhang XL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1087-91, 1095. PubMed ID: 16939890
[TBL] [Abstract][Full Text] [Related]
20. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
Jadvar H; Henderson RW; Conti PS
J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
